Although our understanding of the association between breast implants and anaplastic large-cell lymphoma (ALCL) has increased since the first published case report in 1997,1 questions about this unique clinicopathological entity still outnumber the answers. What causes breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL)? Who is at risk? How great is the risk? What is the optimal treatment?
McCarthy CM, Horwitz SM. Association of Breast Implants With Anaplastic Large-Cell Lymphoma. JAMA Oncol. 2018;4(3):341–342. doi:10.1001/jamaoncol.2017.4467
Oncology in JAMA: Read the Latest
Customize your JAMA Network experience by selecting one or more topics from the list below.